Allogeneic DNT cell therapy synergizes with T cells to promote anti-leukemic activities while suppressing GvHD
Abstract Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a second-line treatment with curative potential for leukemia patients. However, the prognosis of allo-HSCT patients with disease relapse or graft-versus-host disease (GvHD) is poor. CD4+ or CD8+ conventional T (Tconv) cells a...
| Hauptverfasser: | , , , , , , , , , , , , |
|---|---|
| Format: | Artikel |
| Sprache: | English |
| Veröffentlicht: |
BMC
2025-01-01
|
| Schriftenreihe: | Journal of Experimental & Clinical Cancer Research |
| Schlagworte: | |
| Online Zugang: | https://doi.org/10.1186/s13046-024-03247-w |